Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
IE |
|
T
|
Thunder Bridge Capital Partners IV Inc
NASDAQ:THCP
|
US |
|
Next Biometrics Group ASA
OSE:NEXT
|
NO |
|
Maps SpA
MIL:MAPS
|
IT |
|
A
|
Anheuser Busch Inbev SA
F:ITKA
|
BE |
|
DCB Bank Ltd
NSE:DCBBANK
|
IN |
|
N
|
Nexon Co Ltd
OTC:NEXOF
|
JP |
|
PTT Exploration and Production PCL
SET:PTTEP
|
TH |
|
Hiab Oyj
F:C1C1
|
FI |
|
P
|
Perdoceo Education Corp
XMUN:CE1
|
US |
|
N
|
N-Able Inc
NYSE:NABL
|
US |
|
D
|
Deutsche Telekom AG
BMV:DTEN
|
DE |
|
P
|
Precision Wires India Ltd
NSE:PRECWIRE
|
IN |
|
O
|
Orion Oyj
XBER:OFK
|
FI |
|
Century Lithium Corp
XTSX:LCE
|
CA |
Wall St Price Targets
JAZZ Price Targets Summary
Jazz Pharmaceuticals PLC
According to Wall Street analysts, the average 1-year price target for JAZZ is 263.44 USD with a low forecast of 200.66 USD and a high forecast of 322.35 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is JAZZ's stock price target?
Price Target
263.44
USD
According to Wall Street analysts, the average 1-year price target for JAZZ is 263.44 USD with a low forecast of 200.66 USD and a high forecast of 322.35 USD.
What is the Revenue forecast for Jazz Pharmaceuticals PLC?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 4%.
What is the Gross Profit forecast for Jazz Pharmaceuticals PLC?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Jazz Pharmaceuticals PLC?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 22%.
